1-α-Hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women
- 30 June 1997
- journal article
- clinical trial
- Published by Elsevier BV in Bone
- Vol. 20 (6), 557-562
- https://doi.org/10.1016/s8756-3282(97)00054-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: Effects of estrogen therapyJournal of Bone and Mineral Research, 1995
- Calcitriol corrects deficient calcitonin secretion in the vitamin D-deficient elderlyJournal of Bone and Mineral Research, 1994
- Treatment of Postmenopausal Osteoporosis with Calcitriol or CalciumNew England Journal of Medicine, 1992
- Serum Levels of 1,25-(OH)2-Vitamin D are not Altered by Long-Term Supplementation with Alphacalcidol (1-OH-Vitamin D3)Experimental and Clinical Endocrinology & Diabetes, 1992
- Validation of the bone gla protein (osteocalcin) assayJournal of Bone and Mineral Research, 1990
- 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.JCI Insight, 1987
- Increased level of calcitonin mRNA after 1,25‐dihydroxyvitamin D3 injection in the ratFEBS Letters, 1985
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.JCI Insight, 1984
- Acute Effect of 1,25-Dihydroxy-Vitamin D3on Calcitonin Secretion in RatsHormone and Metabolic Research, 1983
- 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue CultureScience, 1972